Antidepressants Market Growth Analysis | 2023-2028

Market Insights

The antidepressants market was estimated at USD 15.3 billion in 2022 and is likely to grow at a CAGR of 3.39% during 2023-2028 to reach USD 18.72 billion in 2028.

Want to know more about the market scope? Register Here

What are antidepressants?

Antidepressants can be defined as drugs that help to alleviate depressive symptoms, anxiety disorders, social anxiety disorder, and dysthymia among others. The antidepressant drugs available in the market include tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonists, and reuptake inhibitors among others.

COVID-19 Impact

The outbreak of the COVID-19 virus has affected the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product supply for a short period and thus, affected the market growth.

Key Players

Key players operating in the market are-

• Alkermes (Ireland)
• Allergan, Inc. (Ireland)
• Bristol Myers Squibb (US)
• Eli Lilly and Company (US)
• GlaxoSmithKline plc (UK)
• H. Lundbeck A/S (Denmark)
• The Merck Group (Germany)
• Pfizer Inc. (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• The Takeda Pharmaceutical Company Limited (Japan)

Market Dynamics

The growth of the antidepressants market is primarily driven by an increasing number of people suffering from depression. The expanding geriatric populace across geographies coupled with rising spending on healthcare is expected to propel the market growth at a significant rate during the review period. Additionally, a growing emphasis on initiatives aimed at creating awareness regarding the disease state is likely to create lucrative opportunities for the market players during the review period.

Want to have a closer look at this market report? Click Here.

Segment Analysis

By End-User Type

By End-User, the antidepressants market has been bifurcated into major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others. Under these, the major depressive disorder segment accounted for the largest market share in 2022 and is projected to register significant growth during the review period. The segment growth can be an increasing number of people suffering from depression.

Regional Insights

By region, the market in North America accounted for the largest market share in 2022 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to the high prevalence of depression, expanding geriatric populace, and presence of key market players such as Bristol Myers Squibb (US) and Eli Lilly and Company (US). The market growth in the Asia-Pacific region is expected to be driven by rising awareness among consumers regarding depression disease in developing countries, particularly China and India.

Know the high-growth countries in this report. Register Here.

Critical Questions Answered in the Report

• What are the key trends in the global market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the global market?
• What are the key strategies adopted by the major vendors to lead in the market?
• What is the market share of the top vendors?

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The antidepressants market is segmented into the following categories.

By Product Type

• Tricyclic Antidepressants
• Selective Serotonin Reuptake Inhibitors
• Serotonin-Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Serotonin Antagonist
• Reuptake Inhibitors
• Others

By End-User Type

• Major Depressive Disorder
• Obsessive-Compulsive Disorder
• Generalized Anxiety Disorder
• Panic Disorder
• Others

By Region

• North America (Country Analysis: The USA, Canada, and Mexico)
• Europe (Country Analysis: Germany, France, The UK, Russia, and The Rest of Europe)
• Asia-Pacific (Country Analysis: Japan, China, India, and the Rest of Asia-Pacific)
• Rest of the World (Country Analysis: Brazil, Argentina, and Others)

Click Here, to learn the market segmentation details.

Target Audience

Here is the list of the group of customers that the antidepressants market hopes to have the greatest opportunity to convert-

• Antidepressants distributors
• Antidepressants suppliers
• Antidepressants manufacturers
• Logistics organizations
• Government bodies

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.

We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@Stratviewresearch.com.